InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,319.31
(
2.30%
)
US TECH 100
18,004.00
(
3.53%
)
Dow Jones
39,446.49
(
1.76%
)
Brent Oil
79.06
(
0.40%
)
Bitcoin
61,441.42
(
-0.48%
)

Replies to post #125983 on Innovation Pharmaceuticals Inc (IPIX)

Replies to #125983 on Innovation Pharmaceuticals Inc (IPIX)
icon url

noretreat

10/15/15 4:25 PM

#125984 RE: noretreat #125983

This is going to be my new mantra....

"Cellceutix reports Kevetrin meets all primary and secondary endpoints in Phase 1 study at Dana-Farber"
icon url

rule_rationale

10/15/15 4:28 PM

#125985 RE: noretreat #125983

We agree. Just saying that the headline excluding 'and secondary' is likely to arrive 6 months minus 4 weeks (5 months) sooner... and be quite well received as well.